This study validated that interference of ILF3 and statins treatment downregulated the phosphorylation PI3K, AKT and mTOR, thereby inhibit the PI3K/AKT/mTOR signaling pathway in GC cells. This evidence concerns the gene ILF3 and gastric cancer.